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Abstract 
 
Escherichia coli O157:H7, a serotype of Shiga toxin producing E. coli (STEC) is responsible for 
numerous food and waterborne outbreaks more  reported in industrialized countries than from 
developing countries. Until recently, no outbreak has been reported in Bangladesh nevertheless 
of their prevalence in the environment. Therefore, the hypothesis of possible immunity present in 
the healthy population in Bangladesh need to be investigated. As outer membrane proteins (omp) 
of E. coli O157:H7 act as important components to stimulate the immune response during 
infection, the present study has been focused on investigating immune response in healthy 
human sera against outer membrane proteins of E. coli O157:H7 isolated and characterized for 
stx 1 and stx 2 positive from local bovine feces and comparing with reference clinical strain of E. 
coli O157:H7 as well. Previously isolated and characterized strains are re confirmed using simple 
biochemical tests for E. coli.  Crude protein extraction is carried out using simple sds-lysis and 
extraction of outer membrane proteins are performed by using Tris-sucrose-EDTA (TSE) buffer. 
For both crude extract and omps, proteins are characterized by SDS-PAGE assay where a 
prominent band of molecular weight 45 kDa is obtained for both vegetables and bovine isolates. 
Western blot experiment showed similar band pattern of 45 kDa in 48 randomly collected 
healthy human sera accompanied by ELISA with different dilutions and one positive and 
negative control. This prominent band of molecular weight 45 kDa has been obtained indicating 
its role as an immunogen. Further, ELISA was performed on 336 randomly collected healthy 
human sera where it clearly indicates the high level of immunogenic response against outer 
membrane proteins is present in all tested human sera indicating the presence of acquired 
immunity in this particular population against the outer membrane proteins. All these data 
strongly suggest the immunogenic role of ~45 kDa outer membrane protein of E. coli O157:H7 
and the evidence that immunity against this protein is present in human sera of Bangladesh. This 
study could explore a new insight in the field of immunology and vaccine development and 
highly demands for further study in vivo. 
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1. Introduction and Literature Review 
1.1 Background 
Escherichia coli has  its  primary niche in the large intestine and lower part of the small intestine 
of mammals, larger birds and reptiles and has been particularly well studied in humans and 
domestic animals. It is a diverse species with both commensal forms and pathogenic forms 
[Zhou et. al., 2010]. 
 
Normally, E. coli bacteria live in the intestines of healthy people and animals. Most varieties of 
E. coli are not dangerous or cause short-lived diarrhea but certain strains, such as E. coli 
O157:H7 can cause severe abdominal cramps, bloody diarrhea and vomiting. E. coli is a Gram-
negative,  facultative anaerobic, rod-shaped bacterium of the genus Escherichia that is commonly 
found in the lower intestine of warm-blooded organisms [Tortora et al., 2012]. 
 
The genus E. coli is named after Theodor Escherich who isolated the type species of the genus. It 
is a gram-negative bacillus occurring singly or in pairs. E. coli is facultative anaerobe  with both 
a fermentative and respiratory type of metabolism. It is either nonmotile or motile by 
peritrichous flagella. E. coli is a major facultative inhabitant of the large intestine and ubiquitous 
in the human environment. It is one of the most frequent causes of the many common bacterial 
infections, including cholecystitis, bacteremia, cholangitis, urinary tract infection (UTI) and 
traveler's diarrhea and other clinical infections such as neonatal meningitis. Since 1885, E. coli 
has been recognized as both a harmless commensal and a versatile pathogen [Bower.,1999]. 
 
E. coli is a  gram negative, rod shaped bacterium  that is  often used in laboratory studies and is  
usually harmless, residing in the human digestive tract as part of the normal flora. E. coli 
O157:H7 is a pathogenic strain of E. coli that was first identified as a cause of disease in the 
United States in 1982, during an investigation into an outbreak of gastrointestinal illness. The 
organism is also called enterohemorrhagic E. coli (EHEC) because it causes abdominal pain with 
diarrhea that may contain blood. It lives in the intestines of healthy cattle and can contaminate 
meat during slaughter. It is believed that the widespread use of antibiotics by American farmers 
has promoted the horizontal gene transfer of antibiotic resistance genes and pathogenicity islands 
that has led to the creation of new pathogenic strains such as E. coli O157:H7. 
In a previous study in Bangladesh, a total of 452 children with diarrhoea and 602 matched 
control children without diarrhoea were investigated for the presence of diarrhoeagenic E. coli 
[Albert et al., 1995]. In children (up to 5 years of age) with diarrhoea, enteropathogenic E. coli 
(EPEC) was the most prevalent (15.5 %), followed by enterotoxigenic E. coli (12 %), 
enteroaggregative E. coli (9.5 %) and diffuse adherent E. coli (8.2 %). Enterohaemorrhagic E. 
coli possessing a stx gene was not detected in any of the children with diarrhoea but was detected 
in five children without diarrhoea. No further characterization of these five isolates was 
performed. Therefore, the specific role of STEC in causing diarrhoeal illness in this area is 
difficult to estimate. The reasons for the low prevalence of STEC-associated diarrhoea among 
hospitalized and community patients are still not clear. However, protective immunity against 
STEC could be an explanation, and was addressed by most of the studies done in developing 
countries [Gianantonio et al., 1964; Lopez et al., 1989; Navarro et al., 2003; Seriwatana et al., 
1988]. This could be associated with the repeated antigenic stimulation in a contaminated 
environment where diarrhoeal diseases are considered endemic [Navarro et al., 2003]. It has also 
been suggested [Beutin et al., 1998] that EPEC infections in early childhood confer cross-
reacting protective immunity against STEC types that share common antigens (such as LPS and 
intimin) with classical EPEC strains.  
 
However, a detailed study of the immune status of patients with diarrhoea as well as healthy 
controls in areas where enteric pathogens are considered to be endemic should be carried out in 
order to explain these phenomena [Islam et al., 2006]. 
 
1.2 Literature Review 
1.2.1 Escherichia coli 
E. coli is a common bacterium that has been studied intensively by geneticists because of its 
small genome size, normal lack of pathogenicity and ease of growth in the laboratory. The 
bacterium E. coli, originally known as Bacterium coli commune, belongs to the Family 
Enterobacteriaceae (Table 1.1) and was first isolated and characterized in 1885 by the German 
scientist and pediatrician Theodore Escherich. The bacteria naturally and harmlessly exists in the 
intestines of all warm-blooded animals, hence the Greek-related root of its Family name, 
Enterikos, meaning “intestine”. It has been stated that the average E. coli population in an adult’s 
intestine is approximately 0.1 percent of the total bacteria. The bacteria are needed by the body 
to aid in the production of several vitamins, such as Vitamin K and the B-Vitamins. E. coli is the 
major component of normal healthy stool. Some species of E. coli co-exist with us nicely; some 
species cause serious disease. Most of the E. coli causes no trouble to humans. Problems arise 
either if E. coli gets somewhere they shouldn’t be (such as the urinary tract) or if people are 
infected by one of the dangerous strains, such as E. coli O157:H7. E. coli is the major cause of 
diarrhea (some mild and some severe) [Bower et al.,, 1999]. It is also a common friendly 
bacterial inhabitant of the intestinal tract, aiding in the digestion of food. In scientific research, E. 
coli is a standard vector for rapid mass production of biological building blocks, from DNA to 
protein. Rare would be a biological researcher who has not used E. coli. The strain found in 
healthy intestines and used in the laboratory is different from the dangerous strain being reported 
in the news. E. coli O157:H7 can be lethal. Its extra genes enable it to stick to the walls of the 
intestine and produce the virulent Shiga toxin, which injures cells in the intestinal walls as well 
as blood vessels in the intestine, leading to bleeding. In the bloodstream, these toxins damage 
other blood vessels, particularly in the kidneys, leading to renal failure. 
 
1.2.2 Morphological features: 
Table 1.1: Classification of E. coli  
Specific classification 
Domain Bacteria 
Kingdom Bacteria 
Phylum Proteobacteria 
Class Gamma Proteobacteria 
Order Enterobacteriales 
Family Enterobacteriaceae 
Genus Escherichia 
Species Escherichia coli (E. coli) 
 
 Domain and Kingdom: E. coli fits into the domain and kingdom of Bacteria because 
members of this group are unicellular microorganisms. 
 Phylum: E. coli fits into the phylum Proteobacteria because members of this group are 
Gram-negative (G-) bacterium with an outer membrane composed primarily of 
lipopolysaccharides. 
 Class: E. coli fits into the class Gamma Proteobacteria because members of this group are 
facultatively anaerobic G- bacterium. 
 Order: E. coli fits into the order Enterobacteriales because members of this group are rod-
shaped facultatively anaerobic G- bacterium. 
 Family: E. coli fits into the family Enterobacteriaceae because members of this group are 
motile via peritrichous flagella that grows well at 37 oC, is Oxidase negative, Catalase 
positive, and reduces nitrates. 
 Genus: E. coli fits into the Genus Escherichia because members of this group are mostly 
opportunistic flora that is enteric (colonize in the intestinal tract of mammals). 
 Species: E. coli is one of five species recognized under the Genus Escherichia.  What makes 
E. coli unique is by these biochemical activities: ferments lactose, possesses lysine 
decarboxylase, is Vogus-Proskauer negative, produces indole, doesn't grow on nitrate, and 
doesn't produce H2S. 
 
1.2.3 Biochemistry of E. coli 
E. coli, is a prokaryotic organism without a nuclear membrane, is a representative living 
material often used in laboratories and class rooms. E. coli reproduces rapidly (under optimal 
situation 0.5 hr/generation) such that results for a number of experiments can be quickly 
obtained. Certain mutants of E. coli have been defined that cannot express certain proteins at 
saturation growth and therefore die. E. coli was also the organism used to elucidate the 
regulation of the lac operon in genetics. Its ability to take up exogenous genetic material under 
the procedure known as DNA-mediated cell transformation has also made it a popular model 
for studies using recombinant DNA. Using recombinant DNA techniques, E. coli can be 
manipulated in research laboratories and in the classroom to produce any DNA, RNA or protein 
of interest. Also, it is easy to manipulate E. coli both genetically and biochemically. Most 
importantly, it shares fundamental characteristics, such as DNA and messenger RNA; with all 
other organisms. The value of E. coli in recombinant DNA makes it a good model organism to 
study the genetic material. An E. coli genome contains between 4200 and 5500 genes, with 
<2000 genes conserved among all strains of the species (the core genome). The bacterium’s 
pan-genome (genetic repertoire of a given species) consists of almost 20,000 genes [Mora et al., 
2011]. Continuous gene flux occurs during E. coli divergence, mainly as a result of horizontal 
gene transfers and deletions. This genetic plasticity accelerates the adaptation of E. coli to 
varied environments and lifestyles, as it allows multiple gene combinations that result in 
phenotypic diversification and the emergence of new hypervirulent (STEC and EAEC 
O104:H4-B1-ST678) and successful (ExPEC O25b:H4-B2-ST131) strains that combine both 
resistance and virulence genes, which in classical pathogenic E. coli strains traditionally have 
been mutually exclusive [Mora et al., 2011]. 
 
1.2.4 Types of E. coli  
Certain isolates of E. coli have been implicated in a wide range of diseases that affect either 
animals or humans worldwide. To date, eight pathovars and their mechanisms of disease have 
been extensively studied. These pathovars can be broadly classified as either diarrhoeagenic E. coli 
or extraintestinal E. coli (ExPEC). Six pathovars-enteropathogenic E. coli (EPEC), entero-
haemorrhagic E. coli (EHEC), enterotoxigenic E.  coli (ETEC), enteroinvasive E. coli (EIEC; 
including Shigella), enteroaggregative E. coli (EAEC), and diffusely adherent E. coli (DAEC) are 
diarrhoeagenic and two pathovars-uropathogenic E. coli (UPEC) and neonatal meningitis E. coli 
(NMEC) are the most common ExPEC isolates. Other pathovars have been identified, but 
their mechanisms of pathogenesis are not as well defined [Croxen and Finlay, 2010]. 
         
i. Enteropathogenic E. coli (EPEC) 
EPEC is a major cause of potentially fatal diarrhea in infants in developing countries [Kaper et 
al., 2004]. They do not possess any colonization factors and do not produce ST or LT toxins. 
They produce a non fimbrial adhesin designated intimin, an outer membrane protein that 
mediates the final stages of adherence. Although they do not produce LT or ST toxins, there are 
reports that they produce an enterotoxin similar to that of Shigella. Other virulence factors may 
be related to those in Shigella [Wellington and vanElsas., 1992]. Adherence of EPEC strains to 
the intestinal mucosa is a very complicated process and produces dramatic effects in the ultra 
structure of the cells resulting in rearrangements of actin in the vicinity of adherent bacteria. The 
phenomenon is sometimes called "attaching and effacing" of cells. EPEC strains are said to be 
"moderately-invasive" meaning they are not as invasive as Shigella, and unlike ETEC or EAEC, 
they cause an inflammatory response. The diarrhea and other symptoms of EPEC infections 
probably are caused by bacterial invasion of host cells and interference with normal cellular 
signal transduction, rather than by production of toxins. They are an important cause of traveler's 
diarrhea in Mexico and in North Africa [Uttly et al., 1998].   
 
ii. Enterohemorrhagic E. coli (EHEC) 
Cattle are a key reservoir for EHEC, which is a highly infectious A/E (human attaching and 
effacing) pathogen that colonizes the distal ileum and large bowel in humans and is often the 
causative agent of outbreaks of severe gastroenteritis in developed countries. Transmission to 
humans usually occurs through contaminated food and water. In North America, Japan and parts 
of Europe, most outbreaks are due to EHEC serotype O157:H7, whereas other serotypes are 
important health concerns in other developed countries. Adults and children infected with EHEC 
suffer from haemorrhagic colitis (bloody diarrhea) and further complications can lead to the 
potentially fatal haemolytic uraemic syndrome (HUS) [Kaper et al., 2004]. EHEC are also considered to 
be "moderately invasive". Nothing is known about the colonization antigens of EHEC but 
fimbriae are presumed to be involved. The bacteria do not invade mucosal cells as readily as 
Shigella but EHEC strains produce a toxin that is virtually identical to the Shiga toxin. The toxin 
plays a role in the intense inflammatory response produced by EHEC strains and may explain the 
ability of EHEC strains to cause HUS. The toxin is phage encoded and its production is 
enhanced by iron deficiency [Griffin et al., 1995; Samuel et al., 1988] 
 
iii. Enterotoxigenic E. coli (ETEC) 
ETEC is an important cause of diarrhea in infants and travelers in underdeveloped countries or 
regions of poor sanitation. The disease varies from minor discomfort to a severe cholera-like 
syndrome. ETEC is acquired by ingestion of contaminated food and water and adults in endemic 
areas evidently develop immunity. The disease requires colonization and elaboration of one or 
more enterotoxins. Both traits are plasmid-encoded. ETEC adhesins are fimbriae which are 
species-specific. For example, the K-88 fimbrial Ag is found on strains from piglets; K-99 Ag is 
found on strains from calves and lambs; CFA I and CFA II are found on strains from humans. 
These fimbrial adhesins adhere to specific receptors on enterocytes of the proximal small 
intestine. Enterotoxins produced by ETEC include the LT (heat-labile) toxin and/or the ST (heat-
stable) toxin, the genes for which may occur on the same or separate plasmids. The LT 
enterotoxin is very similar to cholera toxin in both structure and mode of action. It is an 86 kDa 
protein composed of an enzymatically active (A) subunit surrounded by 5 identical binding (B) 
subunits. It binds to the same identical ganglioside receptors that are recognized by the cholera 
toxin (i.e., GM1) and its enzymatic activity is identical to that of the cholera toxin [Wellington 
and van Elsas., 1992]. 
 
iv. Enteroinvasive E. coli (EIEC) 
EIEC closely resembles Shigella in its pathogenic mechanisms and the kind of clinical illness 
they produce. EIEC penetrates and multiplies within epithelial cells of the colon causing 
widespread cell destruction. The clinical syndrome is identical to Shigella dysentery and includes 
a dysentery-like diarrhea with fever. EIEC apparently lacks fimbrial adhesions but does possess a 
specific adhesion that as in Shigella and is thought to be an outer membrane protein. Also, like 
Shigella, EIEC strains are invasive organisms. They do not produce LT or ST toxin and unlike 
Shigella, they do not produce the Shigella toxin [Wellington and van Elsas., 1992].       
 
v. Enteroaggregative E. coli (EAEC) 
The distinguishing feature of EAEC strains is their ability to attach to tissue culture cells in an 
aggregative manner. These strains are associated with persistent diarrhea in young children.  
They resemble ETEC strains in that the bacteria adhere to the intestinal mucosa and cause non-
bloody diarrhea without invading or causing inflammation. This suggests that the organisms 
produce a toxin of some sort. Recently, a distinctive heat labile plasmid encoded toxin has been 
isolated from these strains, called the EAST (EnteroAggregative ST) toxin. They also produce a 
hemolysin related to the hemolysin produced by E. coli strains involved in urinary tract 
infections. The role of the toxin and the hemolysin in virulence has not been proven. The 
significance of EAEC strains in human disease is controversial [Wellington and van Elsas., 
1992].            
                                        
vi. Diffusely adherent E. coli (DAEC) 
DAEC is a heterogenous group that generates a diffuse adherence pattern on HeLa and HEp-2 
cells. This pattern is mediated by proteins encoded by a family of related operons, which 
includes both fimbrial (for example, Dr and F1845) and afimbrial (Afa) adhesins, collectively 
designated Afa–Dr adhesins [Servin et al., 2005]. DAEC isolates that express any of the Afa–Dr 
adhesins (which are referred to as Afa–Dr DAEC) colonize the small bowel and have been 
implicated in diarrhea in children between the ages of 18 months and 5 years, as well as in 
recurring urinary tract infections (UTIs) in adults [Servin et al., 2005].  
 
vii. Uropathogenic E. coli (UPEC) 
UPEC infections account for roughly 80% of all UTIs, causing cystitis in the bladder and acute 
pyelonephritis in the kidneys. UPEC has the challenge of moving from the intestinal tract to 
establish an infection in the urinary tract, where it uses peptides and amino acids as the primary 
carbon source for fitness [Alteri et al., 2009]. The ability to ascend the urinary tract from the 
urethra to the bladder and kidneys reflects exceptional mechanisms for organ tropism, evading 
innate immunity and avoiding clearance by micturition. Several highly regulated virulence 
factors contribute to this complex pathogenesis, including multiple pili, secreted toxins (for 
example Sat and vacuolating autotransporter toxin (Vat)), multiple iron acquisition systems and a 
polysaccharide capsule [Wiles et al., 2008]. 
 
1.3 Pathogenicity of E.coli: 
The cell-surface structure of Gram-negative bacteria consists of three essential layers: the 
cytoplasmic or inner membrane (IM), the outer membrane (OM) and the periplasmic space 
between the IM and OM. The OM of E. coli has a highly specialized structure and is usually 
associated firmly with the underlying peptidoglycan layer predominantly through 
lipoprotein/matrix protein and linked with cell-surface lipopolysaccharides (LPS). The major 
components of the OM are phospholipids, LPS and proteins which help it to serve as a physical 
barrier between the bacterial body and its surroundings and make the organism resistant to 
protects the cell against bile salts, antibiotics, proteolytic enzymes and other hostile factors and 
also facilities the uptake of nutrients. The aim of the present work was to detect the diversity of 
E. coli collected from different sources estimated by outer membrane protein (OMP).  
 
1.3.1 Detection of E. coli :  Culture-Based Methods 
1.3.1.1 Tryptic Soy Broth 
Tryptic Soy Broth is used for the cultivation of a wide variety of microorganisms. Enzymatic 
Digest of Casein and Enzymatic Digest of Soybean Meal are nitrogen sources in TSB. Dextrose 
is the carbon energy source that facilitates organism growth. Sodium Chloride maintains osmotic 
balance; Dipotassium Phosphate is a buffering agent. [Cunnif et al.,1995] 
 
1.3.1.2 MacConkey Agar 
The agar medium most commonly used for the isolation of E. coli is MacConkey agar. It is a 
selective media which contains lactose as sugar, peptone, sodium chloride, bile salt; inhibits the 
growth of other gram positive Enterobacteriaceae, crystal violet and neutral red is also used to 
understand the nature of fermentation. 
 
MacConkey Agar is recommended for the detection and isolation of Gram-negative organisms 
from clinical, dairy; food, water, pharmaceutical and industrial sources. Enzymatic digest of 
gelatin, enzymatic digest of casein, and enzymatic digest of animal tissue are the nitrogen and 
vitamin sources in MacConkey Agar. Lactose is the fermentable carbohydrate. During Lactose 
fermentation a local pH drop around the colony causes a color change in the pH indicator, 
Neutral Red and bile precipitation. Bile salts mixture and Crystal Violet are the selective agents, 
inhibiting Gram-positive cocci and allowing Gram-negative organisms to grow [Holt and Krieg, 
1994]. Sodium Chloride maintains the osmotic environment. Agar is the solidifying agent. 
 
1.4 Virulence Factors:  
1.4.1 Adhesion/colonization Pathogenic E. coli strains possess specific adherence factors that 
allow them to colonize sites that E. coli does not normally inhabit, such as the small intestine and 
the urethra.. Most frequently these adhesins form distinct morphological structures called 
fimbriae (also called pili) or fibrillae, which can belong to one of several different classes. 
Fimbriae are rod-like structures of 5–10 nm diameters that are distinct from flagella. Fibrillae are 
2–4 nm in diameter and are either long and wiry or curly and flexible [Cassels and Wolf., 1995]. 
The Afa adhesins that are produced by many diarrhoeagenic and uropathogenic E. coli are 
described as afimbrial adhesins, but in fact seem to have a fine fibrillar structure that is difficult 
to visualize [Keller et al., 2002]. Adhesins of pathogenic E. coli can also include outer-
membrane proteins, such as intimin of UPEC and EHEC, or other non-fimbrial proteins. Some 
surface structures trigger signal transduction pathways or cytoskeletal rearrangements that can 
lead to disease. For example, the members of the Dr family of adhesins that are expressed by 
DAEC and UPEC bind to the Decay-Accelerating Factor (DAF also known as CD55), which 
results in activation of phosphatidylinositol 3-kinase (PI-3-kinase) and cell-surface expression of 
the major histocompatibility complex (MHC) class I-related molecule MICA [Tieng et al., 
2002]. The IcsA protein of EIEC nucleates actin filaments at one pole of the bacterium, which 
allows it to move within the cytoplasm and into adjacent epithelial cells on a ‘tail’ of 
polymerized actin [Golderg et al., 1995]. Even surface structures that are present on commensal 
E. coli strains can induce signaling cascades if the organism encounters the appropriate receptor. 
The LPS of E. coli and other Gram-negative bacteria binds to Toll-like receptor 4 (TLR4), 
triggering a potent cytokine cascade that can lead to septic shock and death [Tapping et al., 
2000]. Flagellin, the main component of flagella, can bind to TLR5, thereby activating 
interleukin (IL)-8 expressions and an inflammatory response [Hayashi et al., 2001]. 
 
1.4.2 Toxins 
More numerous than surface structures that trigger signal transduction pathways are secreted 
toxins and other effector proteins that affect an astonishing variety of fundamental eukaryotic 
processes . Concentrations of important intracellular messengers, such as cyclic AMP, cyclic 
GMP and Ca2+, can be increased, which leads to ion secretion by the actions of the heat-labile 
enterotoxin (LT), heat-stable enterotoxin a (STa) and heat-stable enterotoxin b  (STb), 
respectively, all of which are produced by different strains of ETEC [Sears and Kaper,1996]. The 
Shiga toxin (Stx) of EHEC cleaves ribosomal RNA, thereby disrupting protein synthesis and 
killing the intoxicated epithelial or endothelial cells [Melton-Celsa and O’Brien, 1998]. The 
cytolethal distending toxin (CDT) has DNaseI activity that ultimately blocks cell division in the 
G2/M phase of the cell cycle [De Rycke and Oswald., 2001]. Another toxin that blocks cell 
division in the same phase, called Cif (cycle-inhibiting factor), does not possess DNaseI activity, 
but might act by inhibition of Cdk1 kinase activity [Marches et al., 2003]. The cytotoxic 
nectrotizing factors (CNF 1 and CNF 2) deaminate a crucial glutamine residue of RhoA, Cdc42 
and Rac, thereby locking these important signaling molecules in the ‘on’ position and leading to 
marked cytoskeletal alterations, multi nucleation with cellular enlargement, and necrosis [Lerm 
et al.,1999]. The Map protein of EPEC and EHEC has at least two independent activities 
stimulating Cdc42-dependent filopodia formation and targeting mitochondria to disrupt 
membrane potential in these organelles [Kenny et al., 2002]. The various toxins are transported 
from the bacterial cytoplasm to the host cells by several mechanisms. LT is a classic A–B 
subunit toxin that is secreted to the extracellular milieu by a type II secretion system [Tauschek 
et al., 2002]. Several toxins, such as Sat, Pet and EspC are called autotransporters because part of 
these proteins forms a β-barrel pore in the outer membrane that allows the other part of the 
protein extracellular access [Henderson et al., 1998]. The SPATEs (serine protease auto 
transporters of enterobacteriaceae) are a subfamily of serine protease autotransporters that are 
produced by diarrhoeagenic and uropathogenic E. coli and Shigella strains. EPEC, EHEC and 
EIEC contain type III secretion systems, which are complex structures of more than 20 proteins 
forming a ‘needle and syringe’ apparatus that allows effector proteins, such as Tir and IpaB to be 
injected directly into the host cell [Hueck et al., 1998]. The UPEC haemolysin is the prototype of 
the type I secretion mechanism that uses TolC for export from the cell [Balakrishnan et al., 
2001]. No type IV secretion systems have been described for pathogenic E. coli, with the 
exception of the type IV-like systems that are involved in conjugal transfer of some plasmids. 
 
The versatility of the E. coli genome is conferred mainly by two genetic configurations: 
virulence related plasmids and chromosomal pathogenicity islands. All six categories of 
diarrheagenic E. coli have been shown to carry at least one virulence related property upon a 
plasmid. EIEC, EHEC, EAEC and EPEC strains typically harbor highly conserved plasmid 
families, each encoding multiple virulence factors [Hales et al., 1992; Nataro et al., 1987; Wood 
et al., 1986]. McDaniel and Kaper have shown recently that the chromosomal virulence genes of 
EPEC and EHEC are organized as a cluster referred to as a pathogenicity island [McDaniel et al., 
1995; McDaniel and Kaper., 1997]. Such islands have been described for uropathogenic E. coli 
strains [Donnenberg and Wech, 1996] and systemic E. coli strains [Bloch and Rode, 1996] as 
well and may represent a common way in which the genomes of pathogenic and nonpathogenic 
E. coli strains diverge genetically. Plasmids and pathogenicity islands carry clusters of virulence 
traits, yet individual traits may be transposon encoded (such as ST) [So and McCarthy, 1980] or 
phage encoded (such as Shiga toxin) [O’Brien et al., 1992]. 
1.5 EHEC : A deadly pathogenic strain of E.coli  
1.5.1 Virulence factors associated with EHEC 
Enterohaemorrhagic Escherichia coli (EHEC) serotype O157:H7 is an important pathogen that 
can cause a variety of clinical symptoms ranging from mild to severe bloody diarrhoea. The main 
virulence factors of EHEC are Shiga toxins (Stx), responsible for the hemorrhagic syndrome of 
the infection such as hemolytic uremic syndrome (HUS). EHEC is widely distributed in domestic 
ruminants, an important route for transmission to humans. Bovine are the main reservoir for 
EHEC, especially serotype O157:H7 that is transmitted to humans primarily through 
consumption of contaminated foods. Faecal contamination of water and other foods may also 
lead to infection. EHEC can survive and persist in different ecological habitats such as soil, 
manure and aquatic environment. 
 
1.5.2 Pathogenesis and clinical manifestations 
EHEC colonize the gastrointestinal tract and after an incubation period of 2-3 days cause 
diarrhea and abdominal pain. In about 80% of cases after a 2-4 day interval there is progression 
into hemorrhagic colitis (HC) or bloody diarrhea 6. Within 3-13 days after the beginning of 
diarrhea about 10-15% of patients with HC go on to develop a life-threatening condition known 
as hemolytic uremic syndrome (HUS) which includes the triad of microangiopathic hemolytic 
anemia, thrombocytopenia, and acute renal failure. It is the most frequent cause of acute renal 
failure and mortality in children E.Coli O157:H7 is the predominant serotype that has caused 
major outbreaks of gastroenteritis worldwide and is of global concern to public health. Extrarenal 
complications such as rhabdomylosis, myocardial and CNS damage are associated with 
increased mortality in E.coli O157:H7 infections. E.coli O157:H7 belongs to the larger category 
of Shiga toxin producing E.coli (STEC). Shiga toxins (Stxs) produced by EHEC are the major 
virulence factors that are thought to be responsible for the pathogenesis of HUS [Biju et al., 
2014]. 
 
1.5.2.1 EHEC and Human Disease 
HUS and other devastating manifestations of EHEC infection are caused by Stxs, extremely 
potent cytotoxins that enter host cells expressing toxin receptors and block protein synthesis by 
irreversibly damaging ribosomal RNA [Endo et al., 1988].  
EHEC are a subgroup of Stx-producing E. coli (STEC) that together comprise hundreds of O:H 
serotypes and are commonly carried by healthy wild and domesticated ruminant animals [Beutin 
et al., 1993]. 
 
While the attention devoted to EHEC O157:H7 is justified by the pathogenicity, low infectious 
dose, and ability of the bacteria to survive in extra-intestinal environments, a number of non-
O157:H7 EHEC cause severe human disease and are often implicated in HUS and their animal 
reservoirs and modes of transmission are not well understood [Karch et al., 2005]. Non-O157:H7 
EHEC lack the biochemical characteristics differentiating them from nonpathogenic E. coli, and 
thus present a special detection challenge and are perhaps insufficiently investigated [Witold et 
al., 2011]. 
 
1.5.2.2 Identification and Detection of EHEC O157:H7 
1.5.2.2.1 Symptoms 
An EHEC infection can make a person very ill. Symptoms usually begin two to five days after 
ingesting contaminated foods or liquids, and may last for up to eight days or more. The following 
are some of the most common symptoms associated with EHEC. However, each person may 
experience symptoms differently: 
 Abdominal cramps 
 Severe bloody diarrhea 
 Non-bloody diarrhea 
 Little to no fever 
 Fatigue 
 Nausea 
 Hemolytic uremic syndrome (HUS), a serious complication that can lead to kidney 
failure and death 
Symptoms may range from none to HUS. In HUS, an individual's red blood cells (oxygen-
carrying cells in the bloodstream) are destroyed and the kidneys stop working. Approximately 5 
to 10 percent of infections can result in this syndrome. Children and the elderly may be more 
prone to develop this complication, which may be life-threatening. 
 
1.5.2.2.2 Diagnosis 
EHEC can be confirmed with a special stool culture. Stool samples are tested to compare with 
the source or contaminated food that has caused an outbreak. Almost all EHEC O157 display 
delayed (negative) fermentation of D-sorbitol with >99% of the sorbitol-negative H7 strains of 
the O157 serotype [al-Saigh et al., 2004] and resistant to several wide-spectrumantibiotics and 
antimicrobial agents [Ratnam et al., 1988]. The bacteria are commonly identified by plating on 
sorbitol MacConkey agar supplemented with cefixime and potassiumtellurite (CT-SMAC) 
[Chapman et al., 1991] and confirmed serologically and biochemically as pale colonies positive 
for O157 and H7. The probability of detectioncan is greatly increased by nonselective 
enrichment in broth (e.g., buffered peptone water, or McConkey broth) without antimicrobials 
other than novobiocin as fully viable bacteria of some strains may not grow in selective media. 
Low prevalence or EHEC O157 may thus reflect scarcity of the bacteria, but can also result from 
subjecting samples to exacting storage and culture conditions [Witold et al., 2011]. 
 
1.5.3 Sources 
EHEC of the O157:H7 serotype are worldwide zoonotic pathogens responsible for the majority 
of severe cases of human EHEC disease. EHEC O157:H7 strains are carried primarily by healthy 
cattle and other ruminants, but most of the bovine strains are not transmitted to people, and do 
not exhibit virulence factors associated with human disease. Prevalence of EHEC O157:H7 is 
probably underestimated. Carriage of EHEC O157:H7 by individual animals is typically short 
lived, but pen and farm prevalence of specific isolates may extend for months or years and some 
carriers, designated as super shedders, may harbor high intestinal numbers of the pathogen for 
extended periods. Strains of EHEC O157:H7 exhibit high genetic variability but typically a small 
number of genetic types predominate in groups of cattle and a farm environment. Transmission 
to people occurs primarily via ingestion of inadequately processed contaminated food or water 
and less frequently through contact with manure, animals, or infected people [Witold et al., 
2011]. 
 
 
 
 
1.5.3.1 Sources of Human Infection 
1.5.3.1.1 Undercooked contaminated ground beef and other meats 
Ground beef is a particularly efficient transmission vehicle of EHEC due to the ease of cross-
contamination, dispersion of the bacteria throughout the substrate, and poor efficiency of dry 
heat as a sterilizing agent, whereas bacteria contaminating the surface of a meat slab are unlikely 
to survive heat exposure [Witold et al., 2011]. 
 
1.5.3.1.2 Unpasteurized dairy products 
Uncooked/unpasteurized cow and goat milk was a vehicle of infection in several clusters of HUS 
caused by E. coli O157:H7 [Wells et al., 1991; Bielaszewska et al., 1997] and EHEC O157:H7 
were found in sheep dairy products. [Caro et al., 2007] 
 
1.5.3.1.3 Contaminated fresh fruits and vegetables 
Produce provides a variety of vehicles for transmission of EHEC as the bacteria can attach to 
intact or processed fruits and vegetables as well as survive in fruit juice. E. coli O157:H7 
survived for 20 days in apple cider [Besser et al., 1993] and outbreaks were traced to this vehicle 
[Hilborn et al., 2000]. The bacteria can grow in apple tissue and defeat decontamination 
procedures [Janes et al., 2005], although pasteurization is protective, as are some additives [Uljas 
and Ingham., 1999; Comes and Beelman., 2002; Knight and McKellar., 2007]. The ability of 
EHEC O157:H7 to survive and grow in produce is highly dependent on the plant species and 
specific conditions; a cocktail of four strains grew on cut mangoes and papayas at 238 oC, but 
only on papayas at 128 oC; the bacteria survived for at least 180 days on both substrates [Strawn 
and Danyluk., 2009]. 
 
1.5.4 Outbreaks 
1.5.4.1 EHEC outbreak in Japan, 1994 
An outbreak in a nursery school in Japan in late summer to autumn was described by [Akashi et 
al., 1994] of 174 patients examined, there were 101 cases of diarrhoea and 20 cases of HUS; 53 
patients were symptom-free. From 101 diarrhoea cases, EHEC 0157:H7 was isolated from 21 
(20.8%). From 20 cases of HUS, EHEC 0157:H7 was isolated from 14 cases (70%), and it was 
also isolated from seven (13.2%) of 53 symptomless patients. Chapman and Siddons  reported a 
study designed to determine the value of specific methods for isolation of E. coli 0157:H7 from 
faeces. [Goldwater et al.,1998] 
 
1.5.4.2 EHEC outbreak in Germany, May to June 2011 
This year Germany was the starting point of one of the largest ever reported food-borne EHEC 
outbreaks of gastroenteritis and HUS. The latest update indicate that as of July 22, 2011, a total 
of 4075 outbreak cases, 908 of which (23 %) involved HUS, including 34 fatal cases (3.7%) 
have been confirmed. Germany accounted for over 95% of the STEC cases. Other than Germany 
and other EU states, few cases have also been reported from United States of America and 
Canada and can be linked to travel-related exposures in north Germany shortly before becoming 
ill. 
 
In the past decade the other reported cases of HUS associated with this strain include two isolates 
from patients with HUS in Germany in 2001, one in France in 2004, another single case in 2006 
from Korea,two cases of HUS in the Republic of Georgia in 2009, and one case from Finland in 
2010 [Biju et al., 2014]. 
 
1.5.5 Transmission of EHEC O157:H7 
Outbreaks of E. coli 0157:H7 are almost invariably traced to foods of bovine origin. Other foods 
that have been implicated in the spread of E. coli 0157:H7 include apple juice and cider, milk, 
cheese, yogurt, soy beans, lettuce, tomatoes, other fruits and vegetables, and basically anything 
grown on or near herds of cattle. Contaminated water sources such as lakes, ponds and reservoirs 
have also been linked to outbreaks. Person to person transmission is an important source of 
infection by children. This occurs indirectly by the fecal-oral route. Because cattle on farms 
typically live for about 2 years before being slaughtered, long term treatment of cattle would be 
necessary to prevent transmission. 
 
A conceptual distinction should be made between mere retention of viability by the bacteria in 
non-supportive or hostile environments that may provide a conduit for transmission, versus the 
ability of the bacteria to multiply and persist for extended periods in habitats that may form 
environmental reservoirs. EHEC survive well and multiply in raw manure and bedding, but do 
not survive proper composting or waste treatment. E. coli O157:H7 inoculated in moist bovine 
manure initially declined, but subsequently grew to a maximum in 5 days at 378 oC [Delazari et 
al., 1998], EHEC O157:H7 human strain 932 survived best at 228 and 378 oC for up to 70 days 
[Wang et al., 1996], and E. coli O157 survived up to 18 weeks at 158 oC, and 14 weeks at 258 
oC; the best survival occurred with high concentrations of inocula [Fukushima et al., 1999]. 
 
EHEC O157:H7 can be transmitted to humans by contaminated undercooked meat and dairy 
products, produce and fruit juice, drinking and surface water, and, to lesser extent, by contact 
with animals or manure, and person-to-person contact. The bacteria can colonize plants by 
mechanisms distinct from those mediating colonization of mammalian tissues, survive for 
extended time in water and soil, and multiply in manure and other substrates. Survival and 
transmission can be aided by formation of biofilm, and extraintestinal survival can be influenced 
by virulence characteristics [Witold et al., 2011]. 
 
1.5.6 Treatment and prevention 
1.5.6.1 Infection 
EHEC are usually transmitted to humans through the consumption of contaminated food or 
water. EHEC are highly contagious. A low number of pathogen is enough. 
 
1.5.6.2 Clinical course 
After the infection with EHEC bacteria, clinical symptoms such as bloody or bloodless diarrhea 
in combination with abdominal pain and vomiting usually develop after two to ten days. HUS is 
a serious complication that occurs in 5 to 10% of symptomatic EHEC infections and is the most 
common cause of acute kidney failure in young children. 
 
1.5.6.3 Therapy 
Although EHEC are usually susceptible to antibiotic drugs, an antibacterial treatment is not 
recommended since it may lead to increased toxin secretion. Thus, treatment of EHEC is mainly 
supportive. In the case of HUS, dialysis is required to cleanse the body of uremic toxins and to 
maintain fluid and electrolyte balance. 
 
1.5.6.4 Outcome and Prevention 
Without complications, the illness is self limiting and most patients fully recover after about 10 
days. Antibiotics are contraindicated because they have not been shown to be effective in 
altering the course of the illness, may aggravate kidney complications, and contribute to 
antibiotic resistance. Patients with HUS often require blood transfusions and kidney dialysis. 
Almost 40% of patients who survive HUS will have some form of long term damage to their 
kidneys, nervous system or other areas such as the heart, lungs, and pancreas. Bloody diarrhea 
almost always precedes HUS and an early diagnosis is essential for effective treatment. Good 
sanitation and hygiene are essential to preventing E. coli infections. Also, meat should be 
thoroughly cooked at temperatures above 70 oC in order to kill the bacteria and fruits and 
vegetables should be washed before consumption. Proper slaughtering procedures should be 
followed at farms to prevent fecal contamination, although there is currently not enough data to 
recommend ways to prevent contamination of EHEC during the growth, slaughter, processing of 
beef.  
 
1.6. Bangladesh perspective  
1.6.1 Overall pictures of Bangladesh: Spread of infection  
The presence of Shiga toxin 1 or 2 genes, typically acquired by a bacteriophage, qualifies an E. 
coli as a Shiga toxin producing E. coli (STEC). These isolates are also referred to as verotoxin-
producing E. coli (VTEC). Enterohaemorrhagic E. coli (EHEC) is a subset of STEC that was 
originally described by its association with hemorrhagic colitis. EHEC is often LEE positive and 
forms similar attachment and effacing lesions as EPEC.  The most common EHEC serogroup is 
O157:H7 and this serogroup had been responsible for various world-wide outbreaks of 
infection. Of interest, STEC O104:H4, that was recently responsible for major outbreaks of 
hemorrhagic colitis (HC) and  haemolytic uremic syndrome  (HUS) in Europe (especially in 
Germany), can be considered as a hybrid of EHEC and enteraggregative E. coli (EAEC). 
Infections with STEC can range from mild watery  diarrhea to bloody diarrhea (hemorrhagic 
colitis) and the risk of HUS. The first symptom is usually watery diarrhea followed by fever, 
abdominal cramping and vomiting. Both O157 and non-O157 STEC can have similar clinical 
presentations; however, O157 has higher rates of complications such as HC and HUS. Most 
O157:H7 are unable to ferment sorbitol within a 24 hr period and sorbitol MacConkey and 
chromogenic media had been used to detect this serogroup. Shiga toxins can be detected with 
enzyme immunoassay (EIA) and PCR techniques; these tests can also be directly performed on 
stool specimens that will ensure the additional detection of non-O157 isolates. The course of 
infection is usually self-limiting and resolves within 7 days.  Treatment of infection is mostly 
supportive and the use of antibiotics is not recommended. Currently there is no way to prevent 
the development of HUS following STEC infection. Alternative treatment modalities such as the 
use of monoclonal antibodies are ongoing [Albert et al.,1995]. 
 
1.6.2 Outbreaks 
Diarrheal diseases are highly prevalent in Bangladesh. However, the relative contribution of 
diarrheagenic Escherichia coli organisms--those that are enterotoxigenic (ETEC), 
enteropathogenic (EPEC), enteroinvasive, enterohemorrhagic, enteroaggregative, and diffuse 
adherent--to diarrhea in Bangladeshi populations is not known. With DNA probes specific for 
these diarrheagenic E. coli strains, we analyzed fecal E. coli from 451 children up to 5 years of 
age with acute diarrhea seeking treatment at a Dhaka hospital and from 602 matched control 
children without diarrhea from July 1991 to May 1992. Enteroinvasive E. coli was not isolated 
from any children; enterohemorrhagic E. coli was not isolated from any diarrheal children 
[Albert et al.,1995]. 
 
1.6.3 Treatment and prevention available in Bangladesh 
Certain precautions can be followed in prevention of EHEC which are given below: 
 Cooking all ground beef, pork, lamb, or sausage thoroughly.  
 Washing all vegetables and fruits with water, especially if they are not for cooking. 
 Consuming only pasteurized milk and milk products and avoiding raw milk. 
 Consuming only pasteurized juices and ciders. 
 Assuring that infected people, especially children, wash their hands carefully and 
frequently with soap to reduce the risk of spreading the infection. 
 Avoiding swallowing lake or pool water while swimming. 
 Washing hands thoroughly after using the toilet. 
 Washing hands thoroughly after handling animals, animal bedding, or any material 
contaminated with animal feces. 
 People with diarrhea should not: 
o Swim in public pools or lakes 
o Bathe with others 
o Prepare food for others 
A vaccine for cattle is not practical because the bacteria do not cause illness in cattle and 
therefore do not stimulate their immune response. It is recommended that physicians have any 
patient with bloody diarrhea tested for EHEC. There are a variety of ways to detect it in the 
laboratory. It is possible to screen for EHEC by inoculating stool specimens onto MacConkey 
medium containing sorbitol instead of lactose [Albert et al.,1995]. 
 
1.6.4 Current treatment strategies: a multi-targeted approach 
HUS comprises acute renal failure and its consequential perturbation of fluid and electrolyte 
balance, hemolysis, disruption of the clotting cascade with thrombocytopenia, with the risk of 
stroke. This syndrome, together with the further effects of toxin, and complement complex 
formation, must be managed and addressed urgently using a multitargeted approach. This 
involves the institution of general supportive measures, antiplatelet and thrombolytic agents and 
thrombin inhibitors, selective use of antimicrobials, probiotics, toxin neutralizers (synthetic and 
natural binders, antibodies, and so on); and antibodies against key pathogenetic pathway 
elements to interrupt pathological processes (for example, inhibition of terminal complement 
complex formation). Targeting PMNs carrying Stx could be a productive strategy for future 
research, as could possible gene therapy. The management of D+HUS is complex by virtue of 
the nature of the condition and the variety of pathways affected [Goldwater et al.,2012]. 
 
1.7 Antimicrobial resistance 
A wide range of antimicrobial agents effectively inhibit the growth of E. coli. The β-lactams, 
fluoroquinolones, aminoglycosides and trimethoprim-sulfamethoxazole are often used to treat 
community and hospital infections due to E. coli β-lactams disrupt cell wall synthesis by binding 
to and inhibiting the penicillin-binding proteins essential for transpeptidation and 
carboxypeptidation reactions in cell wall peptidoglycan synthesis. Fluoroquinolones interfere 
with DNA supercoiling and promote DNA gyrase-mediated double-stranded DNA. The 
aminoglycosides bind irreversibly to the 50S subunit of the 70S bacterial ribosomes. 
Sulfonamides and trimethoprim interfere with bacterial folic acid synthesis by inhibiting 
tetrahydropteric acid syntheses and dihydrofolate reductase, respectively [Allen et al., 1998]. 
 
1.7.1 Resistance to antimicrobial agents 
The b-lactam antibiotics, especially the cephalosporins and b-lactam-b-lactamases inhibitor 
combinations, are major drug classes used to treat community-onset or hospital-acquired 
infections caused by E. coli, especially due to the ExPEC pathotype.  Among E coli, b-lactamase 
production remains the most important contributing factor to b-lactam resistance. b-lactamases 
are bacterial enzymes that inactivate b-lactam antibiotics by hydrolysis, which results in 
ineffective compounds. 
 
Resistance to aminopenicillins (e.g. ampicillin) and early-generation cephalosporins (e.g. 
cefazolin) among E. coli is often mediated by the production of narrow-spectrum b-lactamases 
such as TEM-1, TEM-2 and to a lesser extent SHV-1 enzyme. Most importantly among E. 
coli, is the increasing recognition of isolates producing the so-called “newer b-lactamases” that 
causes resistance to the expanded-spectrum cephalosporins and/or the carbapenems. These 
enzymes consist of the plasmid-mediated AmpC b-lactamases (e.g. CMY types), extended-
spectrum b-lactamases (e.g. TEM, SHV, CTX-M types), and carbapenemases (KPC types, 
metallo-b-lactamases (MBLs) and OXA-types). CMY, CTX-M, and NDM types of b-lactamase 
are mostly responsible for the emerging resistance to the β-lactam antibiotics among E. coli. The 
VIM, IPM, KPC and OXA-48 β-lactamases had been described in various members of the 
Enterobacteriaceae (especially Klebsiella spp.) and are not yet commonly encountered among E. 
coli [Allen et al., 1998]. 
 
1.7.2 Emerging Trends in Resistance among E. coli 
E. coli, especially the ExPEC pathotype,  is an important cause of community and nosocomial-
acquired infections, especially of urinary tract infections, bloodstream infections, surgical site 
infections, pneumonia and sepsis. The cephalosporins, fluoroquinolones, and trimethoprim-
sulfamethoxazole are considered as 1st line agents and often used to treat community and 
hospital infections caused by E. coli. The management of infections caused by ExPEC has been 
complicated by the emergence of antimicrobial resistance to first line antibiotics. Until the late 
1990s, ExPEC were relatively susceptible to 1st line antibiotics, however severalsurveillance 
studies during the 2000’s across Europe, North and South America, have shown that between 20 
– 55% of ExPEC are resistant to 1st line antibiotics including the 
cephalosporins, fluoroquinolones, and trimethoprim-sulfamethoxazole. Resistance to these 
agents is causing delays in appropriate therapy with subsequent increased morbidity and 
mortality. [Allen et al., 1998] 
 
1.7.3 Plasmid-mediated AmpC-b-lactamases 
E .coli possess a chromosomal gene that encodes for an AmpC β-lactamase. Usually, low 
amounts of these β-lactamases are produced because the AmpC gene is regulated by a weak 
promoter and a strong attenuator system. Occasionally, cephamycin and/or cephalosporin-
resistant E. coli are encountered that produce plasmid-mediated β-lactamases, derived from 
bacteria with chromosomally encoded AmpC-cephalosporinases. E. coli that produce plasmid-
mediated or imported AmpC b-lactamases were first reported in the 1980's. These enzymes (e.g. 
CMY, ACT, FOX, ACT, and DHA types) are derivatives of the chromosomally encoded AmpC 
cephalosporinases of bacteria such as Enterobacter spp., C. freundii, M. morganii, Aeromonas 
spp. and Hafnia alvei and are not inhibited by the “classical” b-lactamase inhibitors such as 
clavulanic acid, sulbactam and tazobactam. However, different types of inhibitors such as 
boronic acid and cloxacillin have the ability to inhibit chromosomal and plasmid-mediated 
AmpC b-lactamases. Resistance to the fourth generation cephalosporins (e.g. cefepime) are 
caused by point mutations in AmpC β-lactamases and is called extended-spectrum 
cephalosporinases. The genes are typically encoded on large plasmids containing additional 
antibiotic resistance genes that are responsible for multi-resistant phenotype, leaving few 
therapeutic options [Allen et al., 1998]. 
 
1.7.4 Metallo-β-lactamases (e.g. NDM-1) 
Recently, a new type of metallo-β-lactamase (MBL), named NDM, was described in K. 
pneumoniae and E. coli recovered from a Swedish patient who was hospitalized in New Delhi, 
India.  MBLs have the ability to hydrolyse a wide variety of b-lactams, including the penicillins, 
cephalosporins and carbapenems, but not the monobactams (i.e. aztreonam), and are inhibited by 
metal chelators such as EDTA.  The majority of NDM-1-producing bacteria are broadly resistant 
to various drug classes and also carry a diversity of other resistance mechanisms (e.g. to 
aminoglycosides and fluoroquinolones), which leaves limited treatment options [Allen et al., 
1998]. 
 
1.7.5 Antimicrobial therapy: Drugs of Choice 
Despite the concerning trends in antimicrobial resistance among E. coli isolates worldwide, a 
growing armamentarium of antimicrobial agents provides multiple options for treating E. 
coli infections. Ironically, these newer agents are more readily available and affordable in 
developed nations where E. coli resistance is less of a problem, compared to the developing 
world.  As with other Enterobacteriaceae, where and when available, antimicrobial testing of the 
infecting strain should direct therapy. In other situations, knowledge of recent local susceptibility 
patterns is useful for guiding treatment. In general, monotherapy with trimethoprim-
sulfamethoxazole, aminoglycoside, cephalosporin, or a fluoroquinolones is recommended as the 
treatment of choice for most known infections with E. coli, although many broad spectrum 
agents (such as ß-lactam/ß-lactamase inhibitor combinations and the carbapenems) remain highly 
active [Allen et al., 1998]. 
 
1.7.6 Treatment of infections due to multi-resistant E. coli 
The presence of ESBLs and AmpC b-lactamases complicates antibiotic selection especially in 
patients with serious infections such as bacteraemia. The reason for this is that these bacteria are 
often multiresistant to various antibiotics and an interesting feature of CTX-M-producing isolates 
is the co-resistance to the fluoroquinolones. Antibiotics that are regularly used for empiric 
therapy of serious community-onset infections, such as the third generation cephalosporins or 
fluoroquinolones are often not effective against ESBL and or AmpC-producing bacteria. This 
multiple drug resistance has major implications for selection of adequate empiric therapy 
regimens. Empiric therapy is prescribed at the time when an infection is clinically diagnosed 
while awaiting the results of cultures and anti-microbial susceptibility profiles.  Multiple studies 
in a wide range of settings, clinical syndromes, and organisms have shown that failure or delay in 
adequate therapy results in an adverse mortality outcome. This is also true of infections caused 
by ESBL-producing bacteria [Allen et al., 1998]. 
 
1.8 EHEC epidemiology: developed versus developing countries 
Diarrhea continues to be one of the most common causes of morbidity and mortality among 
infants and children in developing countries Determination of the etiological agents of diarrhea is 
important in developing rational therapy and in implementing control measures [Albert et 
al.,1995]. 
 
Despite much progress in the understanding of pathogenesis and of management, diarrhoeal 
illnesses remain one of the most important causes of global childhood mortality and morbidity. 
Infections account for most illnesses, with pathogens employing ingenious mechanisms to 
establish disease. In the developed world, an upsurge in immune-mediated gut disorders might 
have resulted from a disruption of normal bacterial-epithelial cross-talk and impaired maturation 
of the gut's immune system. Oral rehydration therapies are the mainstay of management of 
gastroenteritis, and their composition continues to improve. Malnutrition remains the major 
adverse prognostic indicator for diarrhoea-related mortality, emphasising the importance of 
nutrition in early management. Drugs are of little use, except for specific indications although 
new agents that target mechanisms of secretory diarrhoea show promise, as do probiotics. 
However, preventive strategies on a global scale might ultimately hold the greatest potential to 
reduce the burden of diarrhoeal disease. These strategies include vaccines and, most importantly, 
policies to address persisting inequalities between the developed and developing worlds with 
respect to nutrition, sanitation, and access to safe drinking water [Nikhil et al., 2004]. 
 
1.9 Vaccine development: Current pictures 
Several vaccine strategies have been used with variable success in a number of animal models. 
The strategies have involved the use of recombinant virulence proteins such as Stx, intimin and 
E. coli secreted protein A (EspA) or peptides or fusion proteins of A and B subunits of Stx 2 and 
Stx1 such as Stx2Am-Stx1B or avirulent ghost cells of EHEC O157:H7. The application of live 
attenuated bacteria such as Salmonella as a carrier for vaccine proteins against mucosal 
pathogens including EHEC have obvious advantages.  
 
Antibodies produced in humans with HUS and in rabbits immunized with type III secreted 
proteins (T3SPs) from four STEC serotypes, and experimentally infected cattle revealed proteins 
common to several HUS serotypes. These were highly immunogenic in vaccinated and naturally 
infected subjects and represent future candidates for a STEC vaccine.  
 
As well as protein-based vaccines, DNA vaccines are a recent development in EHEC prevention, 
providing encouraging results in a mouse model.  The mode of administration (intramuscular, 
intranasal, oral, intragastric, and so on) for a number of these vaccines not only affects 
immunogenicity but also protective effect under challenge. Vaccination with a plant-based oral 
vaccine protected mice against lethal systemic intoxication with Stx2. This is seen as 
encouraging. Clearly there is some time to go before human trials are reported but the numerous 
and frequent outbreaks of EHEC disease constantly remind us of the urgent need to protect the 
population against these emerging and often devastating zoonoses [Goldwater et al.,2012]. 
 
1.10 Objective of the study:  
Enterohemorrhagic E. coli (EHEC) strains are a class of pathogenic microorganisms responsible 
for numerous food- and waterborne outbreaks, and can cause illness ranging from nonbloody 
diarrhea to copious bloody discharge in humans. In some individuals, the disease progress to a 
more serious stage, and about 2% to 7% of the diarrheal cases (particularly in the pediatric 
population) can be fatal due to acute kidney failure (hemolytic-uremic syndrome [HUS]).  
 
The first outbreak of STEC O157:H7 was recorded in the United States in 1982 and other 
outbreaks occurred later in United Kingdom, continental Europe, Africa, New Zealand and Japan 
over the next decade. In fact, most of the outbreaks were often reported from the industrialized 
countries than from developing countries because of the advanced surveillance and reporting 
systems in the industrialized countries. There are few reports of the prevalence of the Shiga-toxin 
producing E.coli (STEC) in Bangladesh those included the isolation and molecular 
characterizations of these organisms from the diarrheal patients, slaughtered animals, raw meat 
and other food samples. Domestic ruminants are considered the main reservoirs of these 
organisms are highly prevalent in animal reservoirs and in the human food-chain. But no detail 
studies were reported describing the enteropathigenicity or virulence properties of the locally 
isolated STEC O157:H7 from different sources. Also there is no comparative study on the 
bovine and clinical isolates as no STEC O157:H7 has been isolated from patients in the recent 
past in Bangladesh. The aim of the present work was to identify the immune response to 
Escherichia coli O157:H7 in detection of antibodies in healthy human sera against outer 
membrane proteins causing infection in Bangladesh. 
2. Materials and Methods: 
2.1 Working place: 
The experiments of this research study were carried out in the laboratory of the Department of 
Mathematics and Natural Sciences, BRAC University and Department of Microbiology, 
University of Dhaka, Bangladesh. 
 
2.2 Bacterial strains: 
A reference clinical strain E. coli O157:H7 NCTC 12079 and a negative control strain E. coli K-
12 were obtained from the Department of Microbiology, University of Dhaka, Bangladesh. 
Two bovine STEC O157:H7 (CD 11 and CD 17) were isolated from the fresh feces of 18 healthy 
cattle from six different dairy farms around Dhaka city, Bangladesh and were used in the present 
study [Rabbi et. Al., 2013]. 
 
Eight E.coli strains [ASI(7), ASI(8), UFL(14), UFL(17), MBCV2(12), MBCV2(16), ML2(3), 
ML2(7)] isolated from different raw vegetables around Dhaka city. 
 
2.3 Isolation of E. coli strains: 
2.3.1 Isolation of E. coli from vegetable samples 
Twenty five gram of selected raw vegetable was measured and finely chopped aseptically. This 
was added to 225 ml of enrichment broth and homogenized and incubated at 37 oC for 16-18 hr. 
Then 1 ml of enriched broth was subjected to 10-fold dilution series from 10-1 to 10-4 in 9 ml of 
PBS. From each 10-1 to 10-3 dilution tubes, 0.1 ml of suspension was spread plated in duplicate 
onto MacConkey   agar plates. The plates were then incubated at 37 oC for 16-18 hr. 
 
2.3.2 Isolation of E. coli from bovine samples 
A reference clinical strain E. coli O157:H7 NCTC 12079 and a negative control strain E. coli K-
12 were obtained from the Department of Microbiology, University of Dhaka, Bangladesh. Two 
bovine STEC O157:H7 (CD 11 and CD 17) were isolated from the fresh feces of 18 healthy 
cattle from six different dairy farms around Dhaka city, Bangladesh and were included in the 
present study. The isolation and detection procedures of the bovine strains are described below: 
One gram of each bovine feces sample was placed in 9 mL of trypticase soy broth (TSB) 
supplemented with 20 mg/mL novobiocin (Wako, Japan), and incubated at 37 °C for 16-18 h. 
The enriched samples were streaked onto sorbitol MacConkey agar (Oxoid, England) plates 
supplemented with 0.5 mg/L cefixime and 1.5 mg/L potassium tellurite (Sigma, Germany) and 
incubated as above. After incubation, non-sorbitol fermenting colonies were streaked onto eosine 
methylene blue (EMB) agar (Oxoid, England) and 4-methyl-umbelliferyl-β-D-glucuronide 
(MUG) agar (Difco, USA) and incubated at 37 °C for 18-22 hr. Colonies showing green metallic 
sheen on EMB agar and no fluorescence on MUG agar, were characterized by indole production, 
citrate utilization, methyl red, Voges-Proskauer, triple sugar iron and oxidase tests as described 
by [Cappuccino and Sherman., 2011]. Presence of the O157 and H7 antigens in biochemically 
positive colonies were investigated by latex agglutination test kit (WellcolexTM, Remel, USA) 
and the two STEC O157:H7 strains (CD 11 and CD 17) were re-confirmed by PCR targeting the 
rfbO157 and flicH7 genes [Rabbi et. al., 2013]. 
 
2.4 Confirmation of E. coli   Isolates: 
2.4.1 Phenotypic Properties on MacConkey Agar Plate: 
The morphological features of colonies (size, shape, elevation, form, pigmentation and opacity) 
developed after incubation on MacConkey agar plate were carefully studied and recorded. One 
or two E. coli colonies were picked up from the plate and subcultured onto fresh MacConkey 
plate to get pure culture. 
 
2.4.2 Phenotypic Properties on EMB (Eosine methylene blue) Plate: 
Assumed E. coli isolates from the fresh MacConkey plate were streaked onto eosin methylene 
blue (EMB) agar plate for confirmation as E. coli. EMB agar medium contains lactose and the 
dyes eosin and methylene blue that permit differentiation between enteric lactose fermenters and 
non-fermenter. The E. coli colonies are black colonies with a metallic green sheen caused by the 
large quantities of acid that is produced and that precipitates out the dyes onto the growth’s 
surface. [Cappuccino and Sherman., 2011]. 
 
2.4.3 Biochemical Identification:  
Biochemical tests were performed with green metallic sheen producing isolates according to the 
methods described in Microbiology Laboratory Manual [Cappuccino and Sherman., 2011]. The 
biochemical tests performed were indole production test, methyl-red test, Voges-Proskauer test, 
citrate utilization test, triple sugar iron agar test and carbohydrate fermentation (lactose, dextrose, 
sucrose) test. 
 
2.4.3.1 Indole Production Test 
The amino acid tryptophan is a component of nearly all proteins and is therefore available to 
microorganisms as a result of protein breakdown. Some bacteria are able to produce an enzyme 
called tryptophanase that catalyzes the removal of the indole residue from tryptophan. Indole 
accumulates in the culture media while the rest of the tryptophan molecule (pyruvate and NH3) is 
used to satisfy nutritional needs. The production of indole from tryptophan by microorganisms 
can be detected by growing them in a medium rich tryptophan. The accumulation of indole in the 
medium can be detected by adding Kovac’s reagent, which reacts with indole, giving a water-
insoluble bright red compound on the surface of the medium. [Cappuccino and Sherman., 2011]. 
 
2.4.3.2 Methyl Red Test 
The methyl red test is used to detect a specific type of fermentation called mixed acid 
fermentation. Some bacteria ferment glucose and produce large quantities of acidic end products 
that lower the pH of the medium below 5.0. The addition of pH indicator methyl red is used to 
detect this acidity (methyl red is red at pH 4.4 or below and yellow at pH 6.2 or above). A mixed 
acid fermentation is detected by growing bacteria in MR-VP medium and then after an 
incubation period, adding some methyl red reagent to the culture medium. If mixed acid 
fermentation occurred, a yellow color will develop. [Cappuccino and Sherman., 2011]. 
 
2.4.3.3 Voges-Proskaure Test 
The Voges-Proskaure test is used to detect a specific organism that carry out 2, 3-butanediol 
fermentation. When bacteria ferment sugars producing 2, 3-butanediol as a major end product, 
they accumulate this compound in the medium. The addition of 40% KOH and a 5% solution of 
alpha-naphthol in absolute ethanol will reveal the presence of acetoin (acetyl methyl carbinol), a 
precursor in the synthesis of 2, 3-butanediol. The acetoin, in the presence of KOH, will develop a 
pink color imparting a rose color to the medium. The reaction will occur in the presence of 
alpha-naphthol catalyst and a guanidine group that is present in the peptone of the MR-VP 
medium. Aeration increases the rate of oxidation of 2, 3-butanedio to acetoin. [Cappuccino and 
Sherman., 2011]. 
 
2.4.3.4 Citrate Utilization Test 
The citrate test determines the ability of microorganisms to use citrate as the sole source of 
carbon and energy. Simmon’s citrate agar, a chemically defined medium with sodium citrate as 
the carbon source, NH4
+ as a nitrogen source and the pH indicator bromophenol blue, is 
commonly used for this test. When microorganisms utilize citrate, they remove the acid from the 
medium, which raises the pH and turns the pH indicator from green to blue. A color change in 
the medium from green to blue indicates that the microorganisms tested can utilize citrate as its 
only carbon source. [Cappuccino and Sherman., 2011]. 
 
2.4.3.5 Triple Sugar-Iron (TSI) Agar Test 
The triple sugar-iron (TSI) agar test is designated to differentiate among the different groups or 
genera of the Enterobacteriaceae and to distinguish the Enterobacteriaceae from other Gram-
negative intestinal-bacilli. This difference is made on the basis of difference in carbohydrate 
fermentation patterns and hydrogen sulfide production by the various groups of intestinal 
organisms. TSI agar medium contains lactose and sucrose in 1% concentrations and glucose in a 
concentration of 0.1%. To facilitate observation carbohydrate utilization patterns, TSI agar 
medium is made with slant and butt. TSI agar medium also contains sodium thiosulfate and 
ferrous sulfate for detection of hydrogen sulfide production, which is indicated by blackening of 
medium.  [Cappuccino and Sherman., 2011]. 
 
Table 2.1: Types of results observed in TSI test 
Reactions Results 
(a) Alkaline slant (red) and acid butt 
(yellow) with and without gas 
production(breaks in the agar butt) 
Small amount of acid production from 
glucose fermentation and peptone 
utilization have caused alkaline reaction on 
the slant surface. In the butt, acid reaction 
is maintained due to reduced condition and 
slow bacterial growth 
Reactions Results 
(b) Acid slant (yellow) and acid butt 
(yellow) with and without gas production 
Large amount of acid production from 
lactose and/or sucrose fermentation has 
caused acid reaction on the slant surface. 
(c) Alkaline slant (red) and alkali butt (red) 
or no change (orange-red) butt 
No carbohydrate fermentation has 
occurred. Instead peptone has catabolized, 
resulting in alkali reaction. 
 
2.5 Storage of confirmed strains: 
Preparation of stock:  
For short-term preservation, T1N1 agar medium was used.  
 
2.6 Preparation of Crude Extract: Cell Lysis and Protein Extraction 
Historically, physical lysis was the method of choice for cell disruption and extraction of cellular 
contents; however, it often requires expensive, cumbersome equipment and involves protocols 
that can be difficult to repeat due to variability in the apparatus (such as loose-fitting compared 
with tight-fitting homogenization pestles). Also, traditional physical disruption methods are not 
conducive for high throughput and smaller volumes typical of modern laboratory research. In 
recent years, detergent-based lysis methods have become the norm. Through empirical testing by 
trial and error, different detergent-based solutions composed of particular types and 
concentrations of detergents, buffers, salts and reducing agents have been developed to provide 
the best possible results for particular species and types of cells. Detergents have both lysing and 
solubilizing effects. 
 
2.6.1 Cell lysis  
Cell lysis disturbs the carefully controlled cellular environment, allowing endogenous proteases 
and phosphatases to become unregulated. As a result extracted proteins become degraded or 
artifactually modified by the activities of these molecules. To prevent these effects and obtain the 
best possible protein yield in cell lysis, protease and phosphatase inhibitors are added to the lysis 
reagents. Numerous compounds have been identified and used to inactivate or block the 
activities of proteases and phosphatases by reversibly or irreversibly binding to them. 
 When the goal of cell lysis is to purify or test the function of a particular protein, special 
attention must be given to the effects of the lysis reagents on the stability and function of the 
protein(s) of interest. Certain detergents will inactivate the function of particular enzymes, and 
long-term stability of extracted/purified proteins often requires that they be removed from the 
initial lysis reagents and/or stabilized by addition of particular compounds. 
2.6.2 Protein refolding 
Some cell lysis and protein solubilization methods cause the denaturation of proteins. Functional 
tests with such proteins require that they be renatured. Many proteins spontaneously refold into 
their native, functional structures when the denaturing solubilization reagents are removed by 
dialysis. Other proteins, however, will fold into non-functional and even insoluble forms by this 
process. In such cases, specialized sets of buffer conditions must be tested to identify those that 
promote the highest possible yield of properly refolded protein. 
 
2.7 Isolation of Bacteria Envelope Proteins 
Outer membrane proteins (OMPs) of Gram-negative bacteria are key molecules that interface the 
cell with the environment. Traditional biochemical and genetic approaches have yielded a wealth 
of knowledge relating to the function of OMPs. Proteomic analysis on cell envelope proteins 
from Gram-negative bacteria requires specific isolation techniques. The conventional extraction 
methods such as osmotic shock cause extracts to be heavily contaminated with soluble 
cytoplasmic proteins. These cytoplasmic protein contaminants constitute the major signal in 
proteomic analysis and can overwhelm the signals coming from genuine envelope components.  
After extensive testing of various protocols for the preparation of envelope contents, a 
modi fi ed version of the method of Oliver and Beckwith consistently produces the 
cleanest extract of periplasmic and outer membrane proteins.  
2.8 Gel electrophoresis  
Gel electrophoresis is a method for separation and analysis of macromolecules (DNA, RNA and 
proteins) and their fragments, based on their size and charge.It is used in clinical chemistry to 
separate proteins by charge and/or size (IEF agarose, essentially size independent) and in 
biochemistry and molecular biology to separate a mixed population of DNA and RNA fragments 
by length, to estimate the size of DNA and RNA fragments or to separate proteins by charge. 
Nucleic acid molecules are separated by applying an electric field to move the negatively 
charged molecules through an agarose matrix. Shorter molecules move faster and migrate farther 
than longer ones because shorter molecules migrate more easily through the pores of the gel. 
This phenomenon is called sieving.  
 
Gel electrophoresis uses a gel as an anticonvective medium and/or sieving medium during 
electrophoresis, the movement of a charged particle in an electrical field. Gels suppress the 
thermal convection caused by application of the electric field, and can also act as a sieving 
medium, retarding the passage of molecules; gels can also simply serve to maintain the finished 
separation, so that a post electrophoresis stain can be applied. DNA Gel electrophoresis is 
usually performed for analytical purposes, often after amplification of DNA via PCR, but may be 
used as a preparative technique prior to use of other methods such as mass spectrometry, RFLP, 
PCR, cloning, DNA sequencing, or Southern blotting for further characterization. 
 
2.8.1 Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis (PAGE) is used for separating proteins ranging in size from 5 
to 2,000 kDa due to the uniform pore size provided by the polyacrylamide gel. Pore size is 
controlled by controlling the concentrations of acrylamide and bis-acrylamide powder used in 
creating a gel. Care must be used when creating this type of gel, as acrylamide is a potent 
neurotoxin in its liquid and powdered form. 
 
Traditional DNA sequencing techniques such as Maxam-Gilbert or Sanger methods used 
polyacrylamide gels to separate DNA fragments differing by a single base-pair in length so the 
sequence could be read. Most modern DNA separation methods now use agarose gels, except for 
particularly small DNA fragments. It is currently most often used in the field of immunology and 
protein analysis, often used to separate different proteins or isoforms of the same protein into 
separate bands. These can be transferred onto a nitrocellulose or PVDF membrane to be probed 
with antibodies and corresponding markers, such as in a western blot. 
 
Typically separating gels are made in 6%, 8%, 10%, 12% or 15%. Stacking gel (5%) is poured 
on top of the resolving gel and a gel comb (which forms the wells and defines the lanes where 
proteins, sample buffer and ladders will be placed) is inserted. The percentage chosen depends 
on the size of the protein that one wishes to identify or probe in the sample. The smaller the 
known weight the higher the percentage should be used. Changes on the buffer system of the gel 
can help to further resolve proteins of very small sizes.  
 
Proteins, unlike nucleic acids, can have varying charges and complex shapes, therefore they may 
not migrate into the polyacrylamide gel at similar rates, or at all, when placing a negative to 
positive EMF on the sample. Proteins therefore, are usually denatured in the presence of a 
detergent such as sodium dodecyl sulfate (SDS) that coats the proteins with a negative charge. 
Generally, the amount of SDS bound is relative to the size of the protein (usually 1.4 g SDS per 
gram of protein), so that the resulting denatured proteins have an overall negative charge, and all 
the proteins have a similar charge to mass ratio. Since denatured proteins act like long rods 
instead of having a complex tertiary shape, the rate at which the resulting SDS coated proteins 
migrate in the gel is relative only to its size and not its charge or shape. Proteins are usually 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), by native 
gel electrophoresis, by quantitative preparative native continuous polyacrylamide gel 
electrophoresis (QPNC-PAGE), or by 2-D electrophoresis. 
 
Characterization through ligand interaction may be performed by electroblotting or by affinity 
electrophoresis in agarose or by capillary electrophoresis as for estimation of binding constants 
and determination of structural features like glycan content through lectin binding. Proteins are 
usually analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), by 
native gel electrophoresis was followed by coomassie blue staining [Laemmli et al., 1970]. The 
procedure is given below: 
 
 
2.9 Determination of the molecular weight of the protein    
 
To determine the relative mobility (Rf) of the protein, migration distance of the protein was 
divided by the migration distance of the tracking dye. 
 
                               Distance of protein migration. 
             Relative mobility (Rf ) =  ------------------------------------------------------------------------------ 
                                     Distance of the Tracking dye migration. 
 The negative values of (Rf) value were plotted (x-axis) against the  known Log10 molecular 
weight (y-axis) in a graph paper. 
i. A calibration curve was prepared by using the molecular weight standards. 
ii. The molecular weights of the immunogenic proteins were estimated from linear 
calibration curve. 
 
2.10 Estimation of protein concentration: 
The most accurate method of determining protein concentration is probably acid hydrolysis 
followed by amino acid analysis. Most other methods are sensitive to the amino acid 
composition of the protein, and absolute concentrations cannot be obtained. The procedure of 
Lowry et al. is no exception, but its sensitivity is moderately constant from protein to protein, 
and it has been so widely used that Lowry protein estimations are a completely acceptable 
alternative to a rigorous absolute determination in almost all circumstances in which protein 
mixtures or crude extracts are involved. The reactions result in a strong blue color, which 
depends partly on the tyrosine and tryptophan content. The method is sensitive down to about 
0.01 mg of protein/mL, and is best used on solutions with concentrations in the range 0.01–1.0 
mg/mL of protein [Lowry et al., 1951]. 
 
2.11 Collection and separation of blood serum: 
Blood consist of a fluid called plasma in which various groups of formed elements (erythrocytes, 
leukocytes and thrombocytes) are suspended. It is possible to demonstrate the nature of the 
suspension by centrifuging a sample of whole blood in a test tube for a short time at low speed. 
After treatment the heavier cells settle at the bottom and the plasma is visible as pale-yellow 
fluid above them. A thin layer of white cells and platelets are known as buffy coat. 336 in 
number of normal healthy human sera were collected randomly to establish the relationship 
between the heterogeneity and the virulence properties of different groups of strains present in 
healthy human sera. 
 
336 in number of normal healthy human sera were collected randomly from Life and Care 
hospital to establish the relationship between the heterogeneity and the virulence properties of 
different groups of strains present in healthy human sera. 
 
2.12 Relocation of the Protein from the Gel to Nitrocellulose Membrane: Western Blot 
Western blot technique [Towbin et al., 1979] was applied was applied to check the 
immunological profile of the prepared antigen against the human sera. 
 
2.14 Immunological Methods: 
Immunoassays, particularly ELISA, have played a vital role in screening of E. coli from food 
samples and stool specimens. For this, antibodies against particular E. coli, outer membrane 
antigens of that E. coli strain and Shiga toxins are often used [Paton and Paton., 1998]. Latex 
agglutination assay for specific E. coli antigens have greatly facilitated [Nataro and Kaper., 
1998]. An immunomagnetic separation system has recently been developed to reduce the time 
and improve the sensitivity of detection of E. coli. Cytotoxic activity of E. coli present in stool 
on Vero cell line is also an extremely sensitive method to detect the current or recent presence of 
toxin producing E. coli, but this method is time consuming [Khan et al., 2003]. 
 
3. Result 
3.1 Isolation and Identification of E.coli: 
E. coli strains used in this study were isolated from various environmental sources as raw 
vegetables and bovine feces. After appropriate enrichment, selective plating and biochemical 
tests the isolates were further confirmed phenotypically. 
Sixty raw vegetable samples were collected from various local bazaar and super shops around 
Dhaka city. The samples were enriched at 37 oC for 18 hr in enrichment broth containing Bile 
Salt (Figure 3.1). After enrichment; the culture broth was subjected to ten fold dilution series. 
From appropriate dilutions, the broth cultures were spread plated onto MacConkey Agar plates 
and the plates were incubated at 37 oC for 18 hr. After incubation, different types of colonies 
were observed on MacConkey agar plates (Figure 3.2). Colonies showing typical colony 
characteristics of E. coli (Table 3.1) were subcultured onto MacConkey plates. Over 65 isolates 
were taken from primary isolation plates and considered for further investigation. 
   
Figure 3.1: Selective enrichment of various sources: (a) bovine, (b) vegetables. 
 
   
Figure 3.2: (a) Nutrient agar plate showing typical yellow colonies of E. coli 
(b) MacConkey agar plate showing typical pink lactose fermenting colonies of E. coli 
 
Table 3.1: Colony characteristics of E. coli on MacConkey plate 
 Colony characteristics MacConkey plate 
Size Moderate (1-2 mm) 
Shape Round 
Elevation Raised 
Margin Entire 
Color Deep pink Color 
Opacity Opaque 
 
 
 
3.2 Identification of Suspected E. coli Isolates 
3.2.1 Presumptive Identification on EMB Plate 
From MacConkey plates, suspected E. coli isolates were picked up using needle and streaked 
onto EMB agar plates. After incubation, isolates showed green metallic sheen growths were 
selected for further identification (Figure 3.3) and others were discarded. 
 
 Figure: 3.3 EMB agar plate showing typical green metallic sheen growths of presumptive E. coli 
isolates. 
 
3.2.2 Biochemical Identification 
Presumptive isolates which gave metallic green sheen were subjected to different biochemical 
tests. Isolates showed pattern of biochemical reactions typical for E. coli as mentioned in        
(Table 3.2). 
 
 
Table 3.2: Typical results of biochemical tests of E. coli isolates 
Strain ID Indole 
production 
Methyl 
Red (MR) 
Voges 
Proskauer 
(VP) 
Citrate 
utilization 
Triple Sugar Iron 
(TSI) 
STEC 
+ 
+ 
- - Acid butt, acid slant, 
Gas 
K12 
+ + - - 
Acid butt, acid slant, 
Gas 
ASI(7) 
+ + - - 
Acid butt, acid slant, 
Gas 
ASI(8) 
+ + - - 
Acid butt, acid slant, 
Gas 
UFL(14) 
+ + - - 
Acid butt, acid slant, 
Gas 
UFL(17) 
+ + - - 
Acid butt, acid slant, 
Gas 
MBCV2(12) 
+ + - - 
Acid butt, acid slant, 
Gas 
MBCV2(16) 
+ + - - 
Acid butt, acid slant, 
Gas 
ML2(3) 
+ + - - 
Acid butt, acid slant, 
Gas 
ML2(7) 
+ + - - 
Acid butt, acid slant, 
Gas 
CD 17 
+ + - - 
Acid butt, acid slant, 
Gas 
CD 11 
+ + - - 
Acid butt, acid slant, 
Gas 
 
    
      
 
Figure 3.4: Test tubes showing biochemical tests for (a) Indole production, (b) Methyl red and (c) 
Voges -Proskauer test (Negative control, Positive control, Isolates) 
Test tubes showing biochemical tests for (d) citrate utilization, (e) TSI 
 
3.3 Cell lysis and Protein extraction: 
3.3.1 Crude extract:  Bacterial whole cell extract were prepared using simple detergent lysis 
procedure and the  crude extract are used immediately or stored at -20 oC for further study. 
3.3.1 Outer membrane protein extraction: OMPs are extracted according to previously describe 
methods and quantify the amount of total protein present in OMPs extract followed by SDS-
PAGE analysis. 
Table 3.3: Protein estimation outer membrane protein of strain CD 17 (μg/ μl) 
Sample OD From Graph Calc. of OMP (μg/ μl) 
CD 17 0.1855 23.23 3.09 
 
3.4 SDS-PAGE Analysis of the Extracted Protein 
The E.coli surface proteins were extracted by the whole cell lysate method and Tris-sucrose-
EDTA (TSE) extraction procedure. Bands obtained from SDS-PAGE analysis of crude extract 
are shown in (Table 3.5, Table 3.6 and Table 3.7)  were measured by known molecular weight of 
prestained protein marker (Table 3.4). 
 
Table 3.4: Known molecular weight of prestained protein marker 
 
Proteins 
Marker band 
(known MW) 
kDa 
Rf M.Log MW 
Myosin 120 0.04 2.07 
Β-galactosidase 90 0.17 1.95 
Bovine serum albumin 50 0.37 1.69 
Carbonic anhydrase 35 0.55 1.54 
Soybean tripsin inhibitor 26 0.66 1.41 
Lysozyme 20 0.77 1.30 
Table 3.5: Determination of molecular weight of protein in STEC, UFL (14), K12, MBCV2 (12) 
and MBCV2 (16) in kDa from crude extract. 
STEC UFL (14) K12 MBCV2 (12) MBCV2 (16) 
105 105 105 102 102 
102 102 102 91 91 
91 91 91 82 82 
82 82 73 73 73 
73 70 70 66 66 
70 66 66 59 62 
66 59 59 53 53 
62 56 53 45 45 
56 53 45 40 40 
45 45 40 36 36 
40 40 36 34 34 
36 36 34 32 32 
34 34 32 31 31 
32 32 31 29 29 
31 31 29 27 27 
29 29 27 26 26 
27 27 26 24 24 
26 26 22 22 23 
24 22 21 21 21 
22 21 20 20 20 
21 20    
20     
 
 
 
Table 3.6: Determination of molecular weight of protein in UFL (17), ASI (7),  ASI (8) , ML2 
(2) and ML2 (3) in kDa from crude extract. 
UFL (17) ASI (7) ASI (8) ML2 (2) ML2 (3) 
105 105 105 105 105 
102 102 102 102 102 
91 91 91 91 91 
82 82 82 82 82 
70 73 73 73 73 
66 66 66 70 59 
59 62 62 66 53 
56 56 56 62 45 
53 45 45 56 40 
45 40 40 45 36 
40 38 38 40 32 
36 34 34 36 31 
34 31 31 34 29 
32 27 27 32 27 
31 24 24 31 26 
29 22 22 29 22 
27 21 21 27 20 
26 20 20 26  
22   24  
21   22  
20   21  
 
 
 
 
Table 3.7: Determination of molecular weight of protein in CD 17 and CD 11 in kDa from crude 
extract. 
CD 17 CD 11 
105 105 
102 102 
91 91 
82 82 
73 73 
70 70 
66 66 
62 59 
56 56 
45 45 
40 40 
36 36 
34 34 
32 32 
31 31 
29 29 
27 27 
26.3 26.3 
24 24 
22 22 
21 21 
20 20 
 
 
 
3.4.1 Tris-sucrose-EDTA (TSE) extraction procedure: Outer membrane proteins of E. coli 
strains were extracted following TSE extraction method. The observed data are shown in the 
(Table 3.8) and in (Figure 3.5).     
 
 
Figure 3.5: SDS-PAGE Analysis omp of E. coli strains : Lane 1 is Marker protein band and 
Lane 2 to lane 5 is STEC, K12, CD 17 and MBCV2 (12) respectively 
 
 
 
 
 
 
 
Table 3.8: Determination of molecular weight of protein in STEC, K12, CD 17 and MBCV2 
(12) kDa from TSE extraction procedure. 
STEC K12 CD 17 MBCV2 (12) 
105 87 127 127 
50 73 120 120 
45 53 96 96 
 45 87 87 
  82 82 
  78 78 
  62 62 
  53 53 
  45 45 
 
Comparative analysis of groups of SDS-PAGE results of outer membrane proteins among the 
whole cell lysate and the TSE extraction procedure reveals presence of protein bands at ~45kDa 
which gradually shows the similar band patterns in all the isolates from different sources. 
3.5 Western Blot: 
Western blot was performed on 48sera  from 336 randomly collected healthy human sera. A 
representative figure is shown in (Figure 3.6). Bands obtaied in western blot analysis are shown 
in (Table 3.9). 
 Figure 3.6: Western Blot analysis of E.coli outer membrane protein with Human sera. Lane 1 
indicates the marker, lane 2 indicates a female of 48 years, lane 3 indicates a male of 20 years, 
lane 4 indicates a male of 70 years, lane 5 indicates a female of 48 years, lane 6 indicates a 
female of 45 years, lane 7 indicates a female of 30 years, lane 8 indicates a male of 45 years, lane 
9 indicates a male of 38 years, lane 10 indicates a female of 20 years and lane 11 indicates a 
female of 22 years. 
 
Table 3.9: Western Blot analysis of E.coli CD 17 outer membrane protein against human sera 
Lane 1 
(band 
in kDa) 
Lane 2 
(band 
in kDa) 
Lane 3 
(band 
in kDa) 
Lane 4 
(band 
in kDa) 
Lane 5 
(band 
in kDa) 
Lane 6 
(band 
in kDa) 
Lane 7 
(band 
in kDa) 
Lane 8 
(band 
in kDa) 
Lane 9 
(band 
in kDa) 
Lane 
10 
(band 
in 
kDa) 
84 84 84 84 84 84 84 84 84 84 
68 68 68 68 68 68 68 68 68 68 
55 55 45 63 59 55 63 45 63 63 
45 45 38 45 45 45 51 38 45 45 
38 38  38 38 38 45  38 38 
      38    
On the basis of the western blot results the determinated E. coli outer membrane protein was 
found at the band of 45 kDa and 45 kDa. Western blot analysis of neonatal serum was performed 
as control (Figure 3.7). A comparative study is performed on western blot data of both crude 
extract and outer membrane proteins and the protein band of 45 kDa is shown to be prominent in 
both case (Table 3.10).   
 
Figure 3.7: Western Blot analysis of E. coli outer membrane protein analysis with Human sera 
(Neonatal).  
 
Table 3.10: A comparative analysis of the protein band (kDa) between the SDS-PAGE and   
Western blot of strain CD17  
Strain SDS-PAGE Western blot 
CD17 
Crude extract OMP WB 
45 45 45 
 
3.7 Determination of antibody responses using ELISA: Multiple dilutions of the human sera 
(1:100, 1:200, 1:400, 1:800, 1:1600 and 1:3200) were used in ELISA. The STEC positive E. coli 
infected serum was considered as positive control and healthy neonatal human sera as negative 
control (Table 3.11 and Figure 3.8). 
 
Table 3.11: Detection of different primary antibodies against the particular antigen CD 17 
using Human Sera by ELISA: 
 1:100 1:200 1:400 1:800 1:1600 1:3200 
A (negative ctrl) 0.062 0.047 0.033 0.025 0.013 0.005 
B (Sera) 0.480 0.369 0.397 0.210 0.175 0.103 
C (Sera) 0.359 0.284 0.206 0.157 0.116 0.094 
D (Sera) 0.544 0.423 0.328 0.242 0.189 0.132 
E (Sera) 0.439 0.367 0.269 0.188 0.132 0.101 
F (Sera) 0.349 0.295 0.212 0.148 0.104 0.081 
G (Sera) 0.317 0.286 0.227 0.159 0.1145 0.073 
H (positive ctrl) 0.623 0.536 0.422 0.299 0.155 0.084 
 
 Figure 3.8: Immune response of human serum samples against CD 17 by ELISA using different 
dilutions. 
 
 
 
 
 
 
 
 
4. Discussion 
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a zoonotic enteric pathogen associated 
with hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS) in humans. Ruminants are 
the main reservoir of E. coli O157:H7 which usually colonizes the intestinal tract without 
causing clinical signs. Infected animals can shed the bacteria in their feces, so becoming direct or 
indirect sources of human infections via contaminated food or water. For this reason, EHEC 
O157:H7 control in ruminants merits more attention [Zhang et al., 2014]. 
Almost 15 years ago, outbreaks of disease was caused by enterohaemorrhagic Escherichia coli 
(EHEC) O157:H7, this serotype has tended to dominate the world literature on EHEC. Evidence 
suggests that EHEC O157:H7 isolates are derived from one particularly successful clone of E. 
coli that has spread around the world. Long before the emergence of this strain, and ever since, 
there have been reports of human cases and outbreaks of disease caused by serotypes of E. coli 
other than O157:H7. On occasion, these may occur concomitantly with O157:H7 cases, which 
may lead to the false labeling of an outbreak as one caused by this serotype only [Goldwater et 
al., 1998]. 
Without diminishing the role of the O157:H7 clone, it is seen that the importance of recognizing 
that other serotypes are responsible for outbreaks as well as cases of sporadic human disease. It 
is also apparent from the literature that a wide variety of EHEC impinge on the human host from 
a wide range of food and non-food sources. Failure to identify the source is not uncommon. It is 
clear that non-O157:H7 are important (and probably underestimated) causes of disease. Clearly, 
other EHEC will be missed unless they are looked for specifically with a ‘broad brush’ approach 
(like, PCR detection of stx genes or direct detection of toxins in feces or faecal cultures). Medical 
diagnostic and public health laboratories should be encouraged to use techniques that detect stx 
genes or toxins in clinically and epidemiologically appropriate specimens, and should not restrict 
themselves to looking for O157:H7. The current focus on EHEC O157:H7, and seeming neglect 
of other EHEC, has major implications in terms of diagnosis, the food industry and human 
health. In addition, the practice of some authors of implying that EHEC O157:H7 is part of the 
definition of HUS should be discouraged. 5. References: 
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Appendices 
Appendix-I 
Media composition 
 
The composition of the media used in the present study has been given below. Unless 
otherwise mentioned, all the media were autoclaved at 121oC for 15 min.  
MacConkey agar (Oxoid, England) 
 
 
 
 
 
 
2. Eosine methylene blue agar (Oxoid, England) 
Ingredients Amount (g/L) 
Peptone 10.0 
Lactose 10.0 
Di-potassium hydrogen phosphate 2.0 
Eosin Y 0.4 
Methylene blue 0.06 
Agar 15.0 
Final pH 6.8±0.2 
 
3. Simmon’s citrate agar (Oxoid, England) 
Ingredients Amount (g/L) 
Magnesium sulfate 0.2 
Ammonium dihydrogen 
phosphate 
1.0 
Dipotassium phosphate 1.0 
Sodium citrate 2.0 
Sodium chloride 5.0 
Bacto agar 15.0 
Bacto brom thymol blue 0.08 
 
Ingredients Amount (g/L) 
Peptone 20.0 
Lactose 10.0 
Bile salt no. 3 1.5 
Sodium chloride 5.0 
Neutral red 0.03 
Crystal violet 0.001 
Agar 15.0 
pH 7.1±0.2 
4. Triple sugar iron agar 
Ingredients Amount (g/L) 
Bio-polytone 20.0 
Sodium chloride 5.0 
Lactose 10.0 
Sucrose 10.0 
Dextrose 1.0 
Ferrous ammonium sulfate 0.2 
Sodium thiosulfate 0.2 
Phenol red 0.0125 
Agar 13.0 
pH 7.3 
 
5. MR-VP broth 
Ingredients Amount (g/L) 
Peptone 7 g 
Dextrose 5 g 
Di-potassium hydrogen phosphate 5 g 
Final pH 6.9 
 
6. Tryptic soy broth (Oxoid, England) 
Ingredients Amount (g/L) 
Casein peptone 17.0 
Soya peptone 3.0 
Sodium chloride 5.0 
Dipotassium phosphate 2.5 
Dextrose 2.5 
Final pH 7.3±0.2 
 
Peptone water 
Ingredients Amount (g/L) 
Peptone 10 g 
Sodium chloride 5 g 
 
T1N1soft agar 
Ingredients Amount (g/L) 
Tryptone 10 g 
Sodium chloride 10 g 
Agar 6 g 
 
Luria Bertani broth 
Ingredients Amount (g/L) 
Tryptone 10 g 
Yeast extract 5 g 
Sodium chloride 10 g 
 
Nutrient agar 
 
 
 
 
 
 
 
 
 
 
Ingredients Amount (g/L) 
Peptone 5.0 
NaCl 5.0 
Beef extract 3.0 
Agar 15 
Distilled water 1L 
pH 7.0 
Appendix-II 
Buffers and reagents 
 
Kovac’s reagent 
1.25 gm of para-dimethylaminobenzaldehyde was dissolved in 18.75 ml of amylalcohol. 
Then concentrated HCl was added to make the final volume 25 ml. This reagent was covered 
with aluminum foil and stored at 4oC. 
Methyl red reagent 
gm of methyl red was dissolved in 30 ml of 95% ethanol.Then distilled water was 
added to make the final volume 50 ml. This reagent was covered with aluminum foil 
and stored at 4oC. 
Barritt’s reagent 
Solution A 
1.25 gm of alpha-naphthol was dissolved in 95% ethanol with constant stirring to make 25 ml 
solution.This solution was covered with aluminum foil and stored at 4oC. 
Solution B 
10 gm of KOH was dissolved in distilled water. The solution became warm. After cooling to 
room temperature, creatine was dissolved by stirring. Distilled water was added to adjust the 
final volume to 25 ml.This solution was covered with aluminum foil and stored at 4oC. 
 Appendix-III 
Instruments 
The important equipment used through the study are listed below 
Autoclave, Model no: WAC-47 Korea 
Sterilizer, Model no: NDS-600D Japan 
Balance (Core series) Adam, UK 
Centrifuge, Model no (Code: 
5433000.011) 
Eppendorf, Germany 
Digital Homogenizer (Wise Tis)                                             Korea
Freezer (-20°C)                                                                       Siemens, Germeny 
Gel Documentation System                                                    Major Science, Taiwan 
Incubator                                                                                UK
Laminer air flow cabinet                                                          UK 
Micropipettes Eppendorf, Germany 
Oven(Universal drying 
oven)Model:LDO-060E 
Labtech, Singapore 
Thermal Cycler, Model no: 2720                                           Applied Biosystems,USA 
Refrigerator,Model-0636                                                       Samsung
Shaking Incubator (Model-WIS-20R) Korea 
Vortex Mixture    VWR International 
Water bath                                                   Korea 
pH meter, Model: E-201-C                             hanghai Ruosuaa, Technology 
companChina 
Disposable micropippete tips                         Eppendorf, Ireland 
Western blot apparatus                                  Neido, Japan 
 
 
 
 
 
 
 
 
